翻动 发表于 2025-3-26 21:57:25
http://reply.papertrans.cn/47/4647/464687/464687_31.png圆锥 发表于 2025-3-27 03:57:38
http://reply.papertrans.cn/47/4647/464687/464687_32.png食品室 发表于 2025-3-27 05:45:21
The Case for Complement and Inflammation in AMD: Open Questions,Petechiae 发表于 2025-3-27 12:37:47
Multiple Interactions of Complement Factor H with Its Ligands in Solution: A Progress Report,AMITY 发表于 2025-3-27 16:01:11
Genetic Control of Complement Activation in Humans and Age Related Macular Degeneration,闪光东本 发表于 2025-3-27 21:17:40
Bisretinoids of RPE Lipofuscin: Trigger for Complement Activation in Age-Related Macular Degeneraticuticle 发表于 2025-3-27 22:30:01
http://reply.papertrans.cn/47/4647/464687/464687_37.png入伍仪式 发表于 2025-3-28 03:05:34
http://reply.papertrans.cn/47/4647/464687/464687_38.pngdisparage 发表于 2025-3-28 07:37:11
Suppression of Drusen Formation by Compstatin, a Peptide Inhibitor of Complement C3 activation, on会犯错误 发表于 2025-3-28 11:05:56
A Targeted Inhibitor of the Complement Alternative Pathway Reduces RPE Injury and Angiogenesis in M